Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Walker

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Chemical Research in Toxicology|February 15, 2001
Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hydroquinoneS S Lau, T J Monks, J I Everitt, et al.
Molecular Carcinogenesis|September 1, 1995
Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker ratR S Yeung, G H Xiao, J I Everitt, et al.
Molecular Carcinogenesis|January 1, 1997
Characterization of the rat neurofibromatosis 2 gene and its involvement in asbestos-induced mesotheliomaE V Kleymenova, A A Bianchi, N Kley, et al.
Carcinogenesis|December 26, 2001
Protective effect of pregnancy for development of uterine leiomyomaC L Walker, K Cesen-Cummings, C Houle, et al.
Human Nutrition. Applied Nutrition|April 1, 1983
A short dietary questionnaire for use in an epidemiological survey: comparison with weighed dietary recordsJ W Yarnell, A M Fehily, J E Milbank, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 1998
Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and developmentG Rennebeck, E V Kleymenova, R Anderson, et al.
American Journal of Physiology. Cell Physiology|April 18, 2003
Regulation of PDGF production and ERK activation by estrogen is associated with TSC2 gene expressionG A Finlay, D S Hunter, C L Walker, et al.
Environmental Health Perspectives|October 19, 2000
Pregnancy, parturition, and prostaglandins: defining uterine leiomyomasK Cesen-Cummings, J A Copland, J C Barrett, et al.
Annals of the New York Academy of Sciences|January 25, 2002
An in vivo/in vitro model to assess endocrine disrupting activity of xenoestrogens in uterine leiomyomaL C Hodges, D S Hunter, J S Bergerson, et al.
Journal of the Society for Gynecologic Investigation|August 30, 2000
Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyomaC L Walker, K D Burroughs, B Davis, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Chemical Research in Toxicology|February 15, 2001
Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hydroquinoneS S Lau, T J Monks, J I Everitt, et al.
Molecular Carcinogenesis|September 1, 1995
Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker ratR S Yeung, G H Xiao, J I Everitt, et al.
Molecular Carcinogenesis|January 1, 1997
Characterization of the rat neurofibromatosis 2 gene and its involvement in asbestos-induced mesotheliomaE V Kleymenova, A A Bianchi, N Kley, et al.
Carcinogenesis|December 26, 2001
Protective effect of pregnancy for development of uterine leiomyomaC L Walker, K Cesen-Cummings, C Houle, et al.
Human Nutrition. Applied Nutrition|April 1, 1983
A short dietary questionnaire for use in an epidemiological survey: comparison with weighed dietary recordsJ W Yarnell, A M Fehily, J E Milbank, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 1998
Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and developmentG Rennebeck, E V Kleymenova, R Anderson, et al.
American Journal of Physiology. Cell Physiology|April 18, 2003
Regulation of PDGF production and ERK activation by estrogen is associated with TSC2 gene expressionG A Finlay, D S Hunter, C L Walker, et al.
Environmental Health Perspectives|October 19, 2000
Pregnancy, parturition, and prostaglandins: defining uterine leiomyomasK Cesen-Cummings, J A Copland, J C Barrett, et al.
Annals of the New York Academy of Sciences|January 25, 2002
An in vivo/in vitro model to assess endocrine disrupting activity of xenoestrogens in uterine leiomyomaL C Hodges, D S Hunter, J S Bergerson, et al.
Journal of the Society for Gynecologic Investigation|August 30, 2000
Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyomaC L Walker, K D Burroughs, B Davis, et al.
Pageof 11